Sharecast
sharecast
Summary
Sector
Pharma and Biotech
Indices
FTSE AIM
Poolbeg Pharma (POLB)
5.10p
16:55 31/01/25
0.00%
0.00p
Today's Low & High
5.00
/
5.20
Open / Previous Close
5.10 / 5.10
52-week range
-38.92%
-3.25p
Volume
407,738
Market Cap(million)
£25.50m
Advertising
Summary
KEY FINANCIALS
Income & Efficiency
Valuation
Growth
Latest
Forecast
Div Yield
0.0%
n/a
Div Cover
n/a
n/a
Op Mrgn
0.0%
n/a
ROCE
0.0%
Latest
Forecast
P/E
-6.5
n/a
PEG
0.0
n/a
Price / Revenue
0.0
n/a
Price / Book value
1.8
Latest
Forecast
Revenue
n/a
n/a
PBT
0.0%
n/a
EPS
0.0%
n/a
DPS
n/a
n/a
KEY FUNDAMENTALS
Year Ending
Revenue
(£m)
Pre-tax
(£m)
EPS
P/E
PEG
EPS Growth
Div
Yield
2021-12-31
n/a
-2.34
-0.74p
-12.8
0.0
n/a
n/a
0.0%
2022-12-31
n/a
-4.78
-0.94p
-6.4
0.0
n/a
n/a
0.0%
2023-12-31
n/a
-4.51
-0.79p
-11.5
0.0
n/a
n/a
0.0%
Latest Webfg News
Poolbeg Pharma says Gilead in favour of its combination with Hookipa
Sharecast News
10 Jan
Poolbeg Pharma granted new US patent
Sharecast News
20 Nov
Poolbeg agrees 12-month option over potential Behcet's treatment
Sharecast News
30 Apr
More Webfg News
Regulatory News
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
31-Jan-25 11:46
Form 8.5 - Poolbeg Pharma Plc
31-Jan-25 09:14
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
30-Jan-25 10:34
Form 8.5 Poolbeg Pharma Plc
30-Jan-25 09:04
Offer Update - Extension to PUSU Deadline
30-Jan-25 07:01
read more news
Loading: